UPDATE
: Tuesday, December 10, 2019
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
JW Pharmaceutical launches joint-stock company in Vietnam
by Lee Han-soo
2019-11-13 16:52
‘Generic drugs must indicate ingredient names on label’
by Kim Yun-mi
2019-11-13 15:51
Daewoong releases trial results for autoimmune disease treatment in US
by Lee Han-soo
2019-11-12 14:09
Hanmi to get ₩11.6 billion in royalty if FDA approves Rolontis
by Lee Han-soo
2019-11-11 18:02
Genexine’s new immunotherapy shows stability even in high dose
by Jeong Sae-im
2019-11-11 13:36
라인
Medpacto releases trial results at US conference
by Lee Han-soo
2019-11-11 13:27
Yuhan, Cyclica to co-develop new drugs
by Lee Han-soo
2019-11-07 18:01
Takeda’s labor turmoil goes to extremes amid rumored unit sell-off
by Kim Yun-mi
2019-11-07 16:10
‘One-third of heart attack survivors overlook risk of recurrence’
by Lee Han-soo
2019-11-06 16:34
AbbVie’s hepatitis C drug gets 8-week therapy regardless of cirrhosis
by Kim Yun-mi
2019-11-06 16:00
라인
Crystal Genomics, Daehwa win patent for patch-form arthritis drug
by Lee Han-soo
2019-11-06 15:57
Dong-A ST's treatment of nail athlete's foot dominates local market
by Lee Han-soo
2019-11-06 14:09
Regulator to consider re-classifying choline alfoscerate as functional food
by Kim Yun-mi
2019-11-06 13:54
Daewoong to sell Merck's cardiovascular disease treatment
by Lee Han-soo
2019-11-05 15:05
Merck Korea hurries to close GM part despite union’s protest
by Kim Yun-mi
2019-11-05 15:04
라인
[Interview with global pharmas] 'Pfizer Korea combines Pfizer's outstanding innovation with Koreans’ talents'
by Lee Han-soo
2019-11-05 12:46
Yuhan, Dong-A, HanAll see Q3 earnings jump on licensing-out deals
by Jeong Sae-im
2019-11-04 15:52
Takeda Korea fires union leader to worsen labor-management dispute
by Kim Yun-mi
2019-11-04 15:03
Hanmi’s oral anticancer treatment becomes orphan drug in Europe
by Lee Han-soo
2019-11-01 17:50
Life Semantics to unveil its digital drug pipeline next week
by Lee Han-soo
2019-11-01 16:55
-
1
2
3
4
5
6
7
8
9
10
다음
-
Sanofi, Hanmi to look for new partner to commercialize efpeglenatide
Samyang Biopharma USA, Talix Therapeutics to co-develop immunotherapy candidates
Samsung execs get jail term for destroying evidence
Korea selected as 'Medical Tourism Destination of the Year'
Sanofi, Hanmi to look for new partner to commercialize efpeglenatide
Samyang Biopharma USA, Talix Therapeutics to co-develop immunotherapy candidates
Samsung execs get jail term for destroying evidence
Korea selected as 'Medical Tourism Destination of the Year'
여백
Most viewed
1
'Insulin is safe, natural replacement therapy for diabetic patients'
2
Roche Diabetes Care stresses ‘integrated personalized diabetes management’
3
Korean patient with rare breast cancer to sue Allergan in US
4
Gemvax & Kael unveils P2 trial result for Alzheimer treatment
5
Korea exports health insurance system to Bahrain
6
‘Obesity treatment will drastically change next few years’
7
Syntekabio, CHA Hospital to co-develop immunotherapy
8
‘Endogenous T cells have high potential of treating blood, solid tumors’
9
ISU Abxis starts trial of Gaucher disease treatment in Australia
10
AbbVie’s Venclexta nears insurance benefit
여백
Opinion
[Column] Korea should do better in diabetes management
[Column] Digital healthcare for efficient distribution of medical resources
[Reporter’s Notebook] SillaJen should be ashamed of itself
여백
Back to Top